Health Management Plan for Smoker with Heart Disease

Health Management Plan for Smoker with Heart Disease Introduction Cigarette smoking is still the leading cause of preventable death in the developed world. In the UK it is estimated to cause serious illness in 4.5 million people and kills about 300,000 people each year. Frieden estimates that it kills 5 million people in the world annually. (Frieden et al. 2005) This essay will consider the management plan for an idealised patient who smokes and has recently been diagnosed with ischaemic heart disease. There is a great deal of evidence in the literature which links smoking with both increased incidence and increased morbidity and mortality in heart disease. (Molyneux et al. 2004). It follows therefore that every effort should be made to encourage a patient who smokes to quit at the first opportunity. There is some evidence to suggest that one of the optimum times to successfully persuade a patient to quit smoking is when they have had a smoking related health event. (Ferguson et al. 2003) In the context of this essay one can assume that, having just been diagnosed with some form of heart disease, this would be an optimum time to instigate such an intervention. Pathophysiology Cigarette smoking is known to be a major health hazard. It is significantly implicated in virtually all aspects of both cardiovascular morbidity and mortality. (Missel et al. 2008). In terms of pathophysiology, cigarette smoking has an effect on all phases of the atherosclerotic process from the earliest detectable signs of endothelial dysfunction to clinically significant thrombotic clinical events. There appears to be little difference in the implications of active or passive smoking as the effects appear to be largely dose (exposure) related. (Heiss et al. 2008). The mechanisms by which cigarette smoking exerts its pathological effects are complex, but it is known to increase inflammation, enhance the thrombotic processes and increases the oxidation of LDL cholesterol. Cigarette smoking increases the oxidative stress on the body. (OConnell et al. 2008). These smoking-specific effects are accumulative. And there is evidence to support the view that persuading a patient to reduce hi s intake is beneficial, even though this is clearly not as beneficial as complete cessation. (Wood-Baker 2002) Goals Any management plan should ideally have goals. This does not imply that they will all be achieved, but all of the processes identified and activities embarked on should have the ideal goal as their ultimate target. In this particular case, one can define several goals which will assist in the process of smoking cessation and management of their heart disease. A) To ensure that the patient understands their condition. B) Empowerment and education of the patient so that they can participate in their management plan with understanding and commitment C) To assist the patient in the medical treatment of the acute phase of their condition. D) To rehabilitate the patient after the acute stages are stabilised E) To engage with the patient’s carers (formal and informal) to optimise the patient’s return to health F) To assist the patient to quit smoking G) To support the patient as they negotiate their illness trajectory. Clearly there may well be other goals that could be considered and may arise in specific cases. This essay however, is dealing with the generalised patient. These goals are therefore designed to be applicable to the majority of cases of patients who smoke and have heart disease. Assessment The assessment of a patient begins at the first point of contact. Information can be gleaned from many sources and should be appropriate to the presenting condition. Assessment should be holistic and thorough. In this specific case, one should make particular enquiries relating to factors that are relevant to the patient’s lifestyle (relevance to their heart disease) and to their personal habits (relevance to their smoking pattern). One should pay particular attention to the factors that may make them wish to persist in their habit of smoking so that they can be specifically addressed when smoking cessation is discussed. Targeted interventions are more likely to be effective than blanket ones. (Rigotti et al. 2004). In consideration of their heart disease, one should make specific enquiries in relation to their eating and exercise habits as well as their willingness to participate in any proposed lifestyle change programme that may be suggested. Interventions and broad nursing strategies. Clearly the term â€Å"heart disease† covers a multitude of potential pathologies and it is not practical to consider specific interventions for all possibilities. In the context of this essay, one will consider broad strategies which are applicable to most situations. 1) Encourage compliance with drug regimens: Drugs are commonly prescribed in association with heart disease. They can be as part of a primary intervention such as controlling blood pressure (antihypertensives) or perhaps for improving cardiac output (digoxin) or for controlling secondary pathologies (viz. lipid lowering medication, diabetic treatment, anticoagulants). There is a case for using nicotine replacement medication. If this is the case then compliance with an appropriate dose and reducing regime will enhance the likelihood of success. (Parrott et al. 2004) The nurse can assist by encouraging the patient to comply with the regime. They may choose to do this by explaining to the patient why the various drugs are important and how they work or, if compliance is a persistent problem, by acting as the patient’s advocate and discussing with other healthcare professionals if alternative dosing regimes may assist compliance. 2) Facilitate recovery from the illness: This is a vast topic and will, to a large extent, be dependent on the disease process. Clearly the patient who has modest hypertension will require quite different input from the patient who has just sustained a major myocardial infarction. In the acutely debilitated patient, the nurse will need to play a more active and practical role than with the ambulant and largely well patient. Because of the emphasis of this essay on smoking cessation one can specifically include this as a major task in this area of the management plan. The specific details and treatment options will be discussed later. There is evidence that by assisting the patient to quit smoking, this will directly assist in the recovery process from the heart disease. (Siahpush et al. 2003) 3) Provide emotional support: This may be relevant in the patient who smokes primarily for reasons of anxiety or stress. Exploration of the causative factors is clearly relevant if any targeted approaches are going to be effective. If the heart disease is newly diagnosed, additional support may be required to help the patient adapt from a perceived wellness role to an illness role. (Roy. 1991). In this segment one should note that there is some suggestion that the anxiety sometimes caused by the process of smoking cessation can be counter-productive to the treatment of some forms of heart disease. There does not appear to be a strong evidence base to support this intuitive view however. (Sullivan et al. 2007) 4) Prevent the disease: It is known that patients who have smoked will always have a higher lifetime risk of disease than those who have never smoked. Absolute prevention is therefore not possible. Patients who smoke and are then persuaded to stop, can reduce their risks very considerably. It is known that patients who stop smoking will reduce their risks of myocardial infarction by 50% in the first year of smoking cessation. (Prescott et al. 1998) Expected outcome One can hope to assist the majority of patients to quit smoking. To a degree, one has to accept that there will always be a resistant nucleus of individuals who will (for whatever reason) simply not give up. It is not possible to predict, in advance of the intervention, which patients will be in the group that eventually relapses, therefore all patients should be helped equally aggressively. If one considers the results of the Hilleman trial, one is faced with the remarkable prospect that in a study of post CABG patients (who one might assume had the greatest incentive to quit smoking) a staggering 84% were back smoking within 10 weeks of the operation despite a huge input of anti smoking propaganda. (Hilleman et al. 2004) Patient empowerment and education A number of sources highlight patient empowerment and education as one of the prime predictors in a positive decision to quit smoking. (viz. Edwards 2004). If a patient understands the reasoning behind why they are being asked to undertake a health programme they are more likely to comply with it. Education is therefore one of the major factors in the various programmes designed to help patients give up smoking. Empowerment is another prime factor. Many studies have highlighted the need to stress self-belief in the patient and that the degree of self-belief equates strongly with a positive result. (viz. Miller et al. 2003) Smoking cessation A brief overview of the literature on smoking cessation will indicate that the subject is vast and that many different approaches have been tried with varying degrees of success. It is not appropriate to consider all of the various options, but this essay will cover those that appear to have the greatest reported degrees of success. Fung considered interventions that were suitable for hospitalised patients and of the four different regimes trialed, found that a regime which incorporated face-to-face counselling to identify risk factors for smoking Maintenance, individualising advice about quitting, involving patients in education measures (particularly exploration of the health effects and the benefits of quitting), was the most effective. (Fung et al. 2005). The authors also make the comment that the single most effective strategy was to get the smoker to adopt specific coping strategies such as disassociating the act of smoking from their normal daily routine and habits. They were asked not to smoke inside the home or inside the car, not to smoke with coffee or when reading or directly after a meal. Encouraging the family and friends to support them was the next most effective strategy. (Town et al. 2000) Many authorities advocate the use of nicotine replacement therapy (viz. Sullivan et al. 2007). Currently this is available in several presentations with the transdermal patches appearing to give the best rates of prolonged abstinence (about double that of placebo). Even the best results from trials however, do not give a success rate above 35% with the majority giving results in the region of about 20% abstinence at six months. (Hilleman et al. 2004) Follow up Because of the high relapse rate in smoking cessation programmes, follow up is an essential part of the management plan. The literature is full of various follow up strategies ranging from time intensive home follow ups to phone call contacts. It would appear that no one particular form of follow up is significantly more effective than any other. It has been found that any form of follow up is more effective than no follow up at all. Conclusions The evidence base to link cigarette smoking and heart disease is unchallengeable. Advising and helping a patient who has demonstrable heart disease to give up the habit is almost certainly going to have a beneficial effect on their long term health. In reaching this conclusion, one should not loose sight of the fact that there is a substantial failure rate. Any management plan to encourage the patient who smokes to quit, should make use of targeted interventions with follow up and consider using the approaches with optimum outcomes in order to achieve the best achievable response. References Edwards, R (2004) The problem of tobacco smoking. BMJ 328, 217 219 Ferguson, J A, Patten, C A, Schroeder, D R, et al (2003) : Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence. Addict Behav 2003; 28, 1203 1218 Frieden T R, Blakeman D E. (2005) The Dirty Dozen : 12 Myths That Undermine Tobacco Control. American Journal of Public Health . September 2005, Vol 95, No. 9 1500 1505 Fung P R, Snape-Jenkinson S L, Godfrey M T, Love K W, Zimmerman P V (2005) Effectiveness of Hospital-Based Smoking Cessation Chest. 2005; 128 : 216 223. Heiss C, N. Amabile, A. C. Lee, W. M. Real, S. F. Schick, D. Lao, M. L. Wong, S. Jahn, F. S. Angeli, P. Minasi, et al. (2008) Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function : sustained vascular injury and blunted nitric oxide production. J. Am. Coll. Cardiol., May 6, 2008; 51 (18) : 1760 1771. Hilleman D E, Mohiuddin S M, Packard K A (2004) Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies Following Coronary Artery Bypass Graft Surgery. Chest. 2004; 125 : 435 438. Miller, M, Wood, L (2003) Effectiveness of smoking cessation interventions: review of evidence and implications for best practice in Australian health care settings. Aust N Z J Public Health 2003; 27 : 300 309 Missel E, G. S. Mintz, S. G. Carlier, J. Qian, S. Shan, C. Castellanos, R. Kaple, S. Biro, M. Fahy, J. W. Moses, et al. (2008) In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry Eur. Heart J., July 2, 2008; (2008) ehn 293 v1. Molyneux, A Nicotine replacement therapy. BMJ 2004; 328 : 454 456 OConnell E D, J. M Nolan, J. Stack, D. Greenberg, J. Kyle, L. Maddock, and S. Beatty (2008) Diet and risk factors for age-related maculopathy. Am. J. Clinical Nutrition, March 1, 2008; 87 (3) : 712 722. Parrott, S, Godfrey, C (2004) Economics of smoking cessation. BMJ 2004; 328 : 947 949 Prescott E, Hippe M, Schnohr P, Hein H O, Vestbo J. (1998) Smoking and risk of myocardial infarction in women and men : longitudinal population study. BMJ 1998; 316 : 1043 1047 Rigotti, N A, Munafo, M R, Murphy, M F G, et al (2004) Interventions for smoking cessation in hospitalised patients (Cochrane Review). The Cochrane Library. Issue 3, 2004 John Wiley Sons. Chichester, UK: Roy C (1991) An Adaption model (Notes on the Nursing theories Vol 3) OUP : London 1991 Siahpush, M, Borland, R, Scollo, M (2003) Factors associated with smoking cessation in a national sample of Australians. Nicotine Tob Res 2003; 5 : 597 602 Sullivan K M, Seed S E, DeBellis R J. (2007) State of the Art Reviews : Smoking Cessation. A Review of Treatment Considerations . American Journal of Lifestyle Medicine, Vol. 1, No. 3, 201 213 (2007) Town, G I, Fraser, P, Graham, S, et al (2000) Establishment of a smoking cessation programme in primary and secondary care in Canterbury. N Z Med J 2000; 113 : 117 119 Wood-Baker, R (2002) Outcome of a smoking cessation programme run in a routine hospital setting. Intern Med J 2002; 32 : 24 28 ########################################################### 3.8.08 Word count 2,503 PDG

Alternative Fuel Vehicles You Can Buy Today :: Automobiles Environmental Gas Economics Essays

Alternative Fuel Vehicles You Can Buy Today From the earliest days of the automotive industry alternative fuels have always competed with petroleum for powering vehicles. Nicholas Cugnot made the first self-powered road vehicle in 1769 with a steam engine, and the first gasoline automobile didn't appear until over 100 years later from Karl Benz. Through the late 19th and early 20th century steam and electric power remained strong contenders. The invention of the self-starter for gasoline engines by Cadillac eventually proved the undoing of the early steam cars, which required warming up. Electric cars continued to be produced for a while longer, but the expanding road network gradually made their short range of 8-15 miles between charges too inconvenient for many uses. Today we understand that the wholesale burning of petroleum can't continue forever. As the new century opens alternative fuel vehicles are becoming more and more common. Major manufacturers such as Ford, Daimler/Chrysler, and Fiat offer dual fuel cars and trucks now. These vehicles allow you to choose between gasoline and compressed natural gas (CNG) for cleaner emissions. Other large manufacturers such as General Motors, Toyota, and Honda are concentrating on electric vehicles. These global automakers are slowly moving from conventional to alternative power as the technology is developed and refined. Current battery technology allows a maximum range of about 125 miles per charge. The leading edge of electric vehicle technology is occupied by much smaller companies. Bombardier, Pivco AS, and S-LEM AG have designed small, lightweight city cars intended for daily use in dense urban environments. Corbin-Pacific and Zebra Motors have chosen to concentrate on performance. Both companies produce creditable sports cars that just happen to be electrically powered. Do you have an idea that you think will work for an alternatively powered vehicle concept? The U.S. Department of Energy invites small businesses (500 employees or less) to submit grant applications on hybrid electric vehicle technology. Applicants may receive up to $75,000 US for a Phase I grant to develop the feasibility of the idea.Hydrogen VehiclesFuel DescriptionHydrogen is the most abundant element in the universe, but is rarely found in its uncombined form on the earth. When combusted (oxidized) it creates only water vapor as a by-product (4H + O2 = 2 H20). When burned in an internal combustion engine, however, combustion also produces small amounts of nitrogen oxides and small amounts of unburned hydrocarbons and carbon monoxide because of engine lubricants.

Combating corruption Essay

Combating means to take action to reduce or prevent (something bad or undesirable). here in this context we are talking about corruption. So corruption means the misuse of power for own gain. Corruption affects adversely country’s economic development and achievement of developing goals. It promotes in efficiency in utilization of resources, distorts the markets and compromises quality. We know that corruption will not disappear from society. Our efforts are meant to restrict corruption and to protect as much as possible the poor and weak in our societies. In the end all corruption costs are paid by the consumer and the tax payers. They need protection. â€Å"Its the action, not the fruit of the action, that’s important. You have to do the right thing. I may not be in your power, may not be in you time, that there will be any fruit. But that doesn’t mean You stop doing the right thing. You may never know what results come from you action, But if you do nothing, there will be no result.† -Mahatma Gandhi TRANSPARENCY: AN EFFECTIVE TOOL From the very beginning I would like to say that transparency is an effective tool in order for democracy to function and to prevent corruption. Transparency of government means that people can see what’s going on inside a government. The question rises here is that why government hide information from us? I think that hiding is a work of evil as old people says. So hiding information by the government from us is an evil work and when evil word is used in reference with government it mostly refers to CURROPTION. Corruption is the function of both opportunities to request and receive brief and the risk of detection. Corruption exists in every sector of a society. It damages the development of a nation by undermining faith in  public institutions, increases the cost of firm and discouraging the foreign and domestic investigations. According to the Transparency International’s 2009 repot corruption is the most rising challenge for business sectors both developing and industrialized counties. At the individual level, it raises the transaction cost and introduces reputational risk as well as opens up for extortion regardless of the sector and level of transaction, CORRUPTION HAMPER DEVELOPMENT. The UN point out that corruption takes many forms that very in degree, from the minor use of influence to in situationalized bribery. Corruption takes place in offline and online environments. Even if It take place in offline, which no doubt corruption does, it may leave trace online such as interpersonal communications, money transfer and indeed the opposite – lack in transaction.

HIV Speech Essay - 732 Words

HIV Speech It kills over 300,000 people a year. It can affect anyone regardless of your race, sex, or age. It cannot be seen, treated, readily detected or destroyed. It is capable of destroying millions of people without wars or violence. This thing is AIDS caused by the virus HIV-1. What would you do if you found out tomorrow you had AIDS? How would you react if a family member contracted the disease and was diagnosed with one to three years left to live? The HIV virus that causes AIDS began to affect the nation many years ago and was first discovered and documented by the Center for Disease Control in Atlanta, Georgia in 1979. It is an increasingly frightening disease for which no cure has†¦show more content†¦These ARC symptoms may disappear and come back, but more often than not, these symptoms lead up to the serious syndrome of AIDS. Studies have shown that the risk of developing ARC and AIDS increases steadily over the years after a person has first been infected with the HIV- 1 virus. As an AIDS patients immune system deteriorates because of HIV-1, he tends to develop a variety of recurrent or chronic infections. These infections are normally harmless to people with healthy immune systems, but are very dangerous to AIDS patients. In the third stage of AIDS, the patients helper T cell count is down to a very dangerous level. Here, common illnesses that are normally easily defeated such as pneumonia and tumors are deadly to an AIDS patient. He may also suffer from a mental illness known as dementia. After this stage, there is little hope left for a patient. Frequent illness persists and diseases that were extinct for long periods of time flare up in this unhealthy immune system. Always, the cause is death. It should be noted however that the AIDS virus itself does not cause death. Death is caused by the bodys inability to defend itself against other invading virii. As said earlier, AIDS is caused by the virus HIV-1. This virus is a single strand of RNA which travels in the blood. HIV-1 is aShow MoreRelatedOutline Of A Speech On Hiv And Aids1284 Words   |  6 PagesTitle of Speech:____Hemophilia and HIV/AIDs in the modern world__________ I. Introduction: (attention getter and transition to get to thesis) Attention Getter: About 400,000 people are living with hemophilia, a rare blood disorder that causes blood to clot abnormally. Many of these people also develop HIV and AIDS, an immune deficiency. Even more shocking is the 78 million people living with HIV. All of these conditions are lifelong and fatal. Over 40 million people each year die of HIV or hemophiliaRead MoreMary Fisher s Speech : A Whisper Of Aids886 Words   |  4 PagesMary Fisher’s speech entitled â€Å"A Whisper of Aids,† is an appeal to the emotional and political moods of the Republican National Conference on August 19, 1992. In this speech she talks about her disease, but unlike most people, who become depressed when they learn about contracting the disease, Mary Fisher stands up and fights for everyone who has AIDS as well as bringing the statics of HIV and AIDS to light. Mary Fisher’s speech can be analyzed from three different standpoints: structure, deliveryRead MoreA Whisper Of Aids, By M ary Fisher1369 Words   |  6 PagesFisher s A Whisper of AIDS speech, the use of pathos and ethos assists in her demand to end the ignorance, prejudice and silence surrounding HIV/AIDS. I will discuss how she replaces the face of AIDS with her own, allowing the conservative crowd to connect with HIV/AIDS. Fisher approaches the speech as an epidemic speech; heavily relying on ethos and pathos she created compassion and connection to an audience that usually shows disinterest and silence on the topic of HIV/AIDS. This paper will alsoRead MoreAnalysis Of A Whisper Of Aids By Mary Fisher1099 Words   |  5 Pagesthe HIV virus, however, such speculation was disregarded once millions of people were infected. Humans were afraid to be infected, thus they stereotyped those who were infected in order to protect themselves, but the reality is that no one was safe from the HIV virus. Mary Fisher was one of few individuals that accepted the cruelty of the virus, but only by accepting what HIV is, she was able to challenge the virus. In order to awaken the society about the reality of AIDS, Mary Fisher’s speech, â€Å"ARead MoreThe Dangers Of Hiv And Aids977 Words   |  4 PagesNational Convention Address in Houston, Texas. Mary Fisher the daughter of the wealthy and powerful Republican fund raiser Max Fisher conducted her speech on the dangers of HIV and AIDS. A forty-four year old HIV positive mother of two was infected with this disease through her ex-husband. Fisher said throughout her speech â€Å"I would never have asked to be HIV positive, but I believe that in all things there is a purpose†. During the year of 1992, millions of people were infected with this disease butRead MoreMary Fisher Speech Summary846 Words   |  4 PagesDuring the late 1990s, the HIV virus spread to different parts of the world affecting millions of people and causing the death of many people. The spread of the virus brought fear to many people, especially those in Am erica. Negative attitudes toward those with HIV or AIDS grew which made those with the virus feel ashamed of being exposed to the virus. Mary Fisher argues that raising awareness of HIV/AIDS is necessary to not only prevent the spread of the virus but to also help support those, notRead MoreThe Developmental Stages Of Psychological Development1494 Words   |  6 PagesVirus (HIV). This virus alters the immune system and has a specific affinity for the nervous system, where it causes a series of neurological traumas. HIV is able to cross the blood brain barrier and enter the nervous system through monocytes, early in the course of infection, probably concomitantly with initial systemic infection. The virus can damage or kill nerve cells either by viral replication or toxic effects. HIV can lie dormant in the nervous system, and hence, the initial seeding of HIV onRead MoreThe Developmental Stages Of Psychological Development1466 Words   |  6 PagesVirus (HIV). This virus alters t he immune system and has a specific affinity for the nervous system, where it causes a series of neurological traumas. HIV is able to cross the blood brain barrier and enter the nervous system through monocytes, early in the course of infection, probably concomitantly with initial systemic infection. The virus can damage or kill nerve cells either by viral replication or toxic effects. HIV can lie dormant in the nervous system, and hence, the initial seeding of HIV onRead MoreMary Fisher: the Struggle to Inform1223 Words   |  5 Pagescome along with it. Mary Fisher is an AIDS community member and is not afraid to stand up and say so. Defending and helping those with HIV/AIDS and helping them spread the word instead of keeping silent. In 1991 she found out that she had contracted the disease from her second husband and now Fisher is one of the world’s leading activists in the fight against HIV/AIDS. (Newman, 2010) On August 20, 1992, Mary Fisher addressed the Republican National Convention in Houston. She spoke for ten minutesRead MoreThe First Official Documentation Of Acquired Immune Deficiency Syndrome927 Words   |  4 Pageswoman by the name of Mary Fisher gave a speech, 1922 Republican National Convention Address. She gave this speech for the purpose of informing the world she had been diagnosed with Aids and the disease should not be ignored and that this disease does not discriminate. In her speech, she wanted everyone to realize the importance of knowing about this disease and people that have it should not keep it a secret, it shouldn t be hidden. In addition, in her speech she talks directly to her audience to